primary myelofibrosis

Explore academic connections and research related to this keyword

223
Views
49
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
t(15; 17) associated with primary myelofibrosis: a case report of an unusual clinical presentation and diagnostic dilemma.
Nadiminti, Kalyan;Silverman, Margarida;Bhagavathi, Sharathkumar;Vikas, Praveen;
2019 OncoTargets and therapy DOI: 10.2147/OTT.S208290 320 views
2
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.
Iurlo, Alessandra;Elli, Elena Maria;Palandri, Francesca;Cattaneo, Daniele;Bossi, Anna;Cortinovis, Iv...
2019 hematological oncology DOI: 10.1002/hon.2658 218 views
3
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis.
Pugliese, Novella;Giordano, Claudia;Nappi, Davide;Luciano, Luigiana;Cerchione, Claudio;Annunziata, M...
2019 Cancer medicine DOI: 10.1002/cam4.2147 235 views
4
Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups.
Murata, Makoto;Takenaka, Katsuto;Uchida, Naoyuki;Ozawa, Yukiyasu;Ohashi, Kazuteru;Kim, Sung-Won;Ikeg...
2019 biology of blood and marrow transplantation : jour... DOI: S1083-8791(19)30144-... 217 views
5
Recurrent ischaemic cerebrovascular events as presenting manifestations of myeloproliferative neoplasms.
Stefanou, M I;Richter, H;Härtig, F;Wang, Y;Örgel, A;Bender, B;Mengel, A;Ziemann, U;Poli, S;
2019 European journal of neurology DOI: 10.1111/ene.13907 280 views
6
Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?
Sankar, Kamya;Stein, Brady L;
2018 journal of the national comprehensive cancer netwo... DOI: 10.6004/jnccn.2018.7... 272 views
7
ruxolitinib treatment in a patient with primary myelofibrosis resistant to conventional therapies and splenectomy: a case report
;Meltem Aylı;Muhit Özcan;Güldane Cengiz Seval
2015 proceedings of the international conference on iot... DOI: 10.4274/tjh.2013.033... 155 views
8
the european clinical, molecular, and pathological (ecmp) criteria and the 2007/2008 revisions of the world health organization for the diagnosis, classification, and staging of prefibrotic myeloproliferative neoplasms carrying the jak2v617f mutation
;Jan Jacques Michiels;Fibo Ten Kate;King H. Lam;Wilfried Schroyens;Zwi Berneman;Hendrik De Raeve
2014 proceedings of the international conference on iot... DOI: 10.4274/Tjh.2013.013... 400 views
9
A conditional inducible JAK2V617F transgenic mouse model reveals myeloproliferative disease that is reversible upon switching off transgene expression.
Chapeau, Emilie A;Mandon, Emeline;Gill, Jason;Romanet, Vincent;Ebel, Nicolas;Powajbo, Violetta;Andra...
2019 PloS one DOI: 10.1371/journal.pone... 307 views
10
Management of advanced phase myeloproliferative neoplasms.
Marcellino, Bridget;Mascarenhas, John;
2019 clinical advances in hematology & oncology : h&o 273 views
11
Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms.
Arachchillage, Deepa Rj;Laffan, Mike;
2019 seminars in thrombosis and hemostasis DOI: 10.1055/s-0039-16934... 260 views
14
Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Sankar, Kamya;Stein, Brady L;Rampal, Raajit K;
2019 cancer treatment and research DOI: 10.1007/978-3-030-20... 274 views
15
How I treat polycythemia vera.
Spivak, Jerry L;
2019 Blood DOI: 10.1182/blood.201883... 241 views
18
Heterogeneity in myeloproliferative neoplasms: Causes and consequences.
O'Sullivan, Jennifer;Mead, Adam J;
2019 advances in biological regulation DOI: S2212-4926(18)30157-... 256 views
19
Somatic Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Ferreira Cristina, Sérgio;Polo, Blanca;Lacerda, João F;
2018 seminars in hematology DOI: S0037-1963(17)30169-... 247 views
20
Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management
Tefferi, A.
2018 American journal of hematology DOI: 10.1002/ajh.25230 228 views
21
Revised myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia
Agarwal, M.
2018 indian journal of medical and paediatric oncology DOI: 10.4103/ijmpo.ijmpo_... 256 views
22
Recent advances in the diagnosis and management of primary myelofibrosis
Takenaka, K.
2018 korean journal of internal medicine DOI: 10.3904/kjim.2018.03... 202 views
23
Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement
Sliwa, T.
2017 wiener klinische wochenschrift DOI: 10.1007/s00508-016-1... 211 views
24
Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management
Tefferi, A.
2016 American journal of hematology DOI: 10.1002/ajh.24592 189 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

fish case report atypical t(15;17) cytogenetics prognosis bone marrow fibrosis driver mutations risk categories ruxolitinib hydroxyurea janus kinase (jak) inhibitors allogeneic transplantation unrelated donor stroke myeloproliferative neoplasms essential thrombocythemia polycythemia vera jak2 mutation myeloproliferative neoplasm Migration